The BenchSci Blog

Artificial Intelligence in Drug Discovery Jun 20, 2018
Shai Shen-Orr, Chief Scientist of CytoReason, on AI for Systems Immunology
Artificial Intelligence in Drug Discovery Jun 11, 2018
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
BenchSci Analysis Jun 7, 2018
Mammalian Model Organisms: Contributions and Limitations
BenchSci Case Studies Jun 1, 2018
Dr. David Rimm on Antibodies, Reproducibility, and His Experience with BenchSci
Research Tips May 30, 2018
The Current State of Alzheimer’s Disease Biomarkers
Artificial Intelligence in Drug Discovery May 29, 2018
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
BenchSci Updates May 21, 2018
Data Update: More Antibodies and Figures, Closed-Access Content, and New Filters
Career Development May 17, 2018
7 Tips to Apply for a Non-Academic Job with a Life Science PhD
Therapeutic Antibodies May 16, 2018
Recent Advances in Treatment of Stage IV Metastatic Breast Cancer: Anti-HER2 mAbs, TKIs, and ADCs
Artificial Intelligence in Drug Discovery May 16, 2018
Mauro Cozzi, Co-founder of Researchably, on AI for Better Biomedical Search
Artificial Intelligence in Drug Discovery May 14, 2018
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Research Tips May 2, 2018
A Novel Method to Evaluate Clinical Efficacy of Pre-Infusion CD19 CAR-T Products

Never miss a blog post